Funding

RQ Bio

United Kingdom · Biotech · Healthtech · Enterprise software

Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients

Visit rqbiotechnology.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$115MEQT Life Sciences — Role not disclosedForbion — Role not disclosedFrazier Life Sciences — Role not disclosedLifeArc — Role not disclosedMonograph — Role not disclosedOxford Science Enterprises — Role not disclosedOxford University Innovation — Role not disclosedWellington Management — Role not disclosed

Investors

EQT Life SciencesSeries AForbionSeries AFrazier Life SciencesSeries ALifeArcSeries AMonographSeries AOxford Science EnterprisesSeries AOxford University InnovationSeries AWellington ManagementSeries A

Coverage

Jun 24, 2026RQ Bio · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Sourcesrqbiotechnology.com ↗